Evaxion A (EVAX) Interest Coverage Ratio (2020 - 2026)
Evaxion A (EVAX) reported Interest Coverage Ratio of 11.5 for Q1 2026, up 18.06% on a YoY basis from 9.74 in Q1 2025, and up 680.12% quarter-over-quarter from 1.47 in Q4 2025.
Evaxion A (EVAX) Interest Coverage Ratio (2020 - 2026) Analysis & Trends
Evaxion A has reported Interest Coverage Ratio for 7 years, with the latest figure at 11.5 in Q1 2026.
- For the quarter ending Q1 2026, Interest Coverage Ratio rose 18.06% year-over-year to 11.5; the trailing twelve-month figure through Mar 2026 stood at 1.62 (down 62.65% YoY), and the FY2025 full-year result was 1.61, down 65.87% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 11.5, up from 1.47 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 40.5 in Q1 2022, with the low at 2.22 in Q3 2025.
- Historically, Interest Coverage Ratio has averaged 13.24 across 5 years, with a median of 11.06 in 2022.
- Annual changes were most pronounced in 2023 — Interest Coverage Ratio jumped 178.44% — and 2025, when it slumped 149.29%.
- Evaxion A's Interest Coverage Ratio stood at 11.06 in 2022, then sank by 55.91% to 4.88 in 2023, then surged by 80.19% to 8.79 in 2024, then sank by 83.22% to 1.47 in 2025, then soared by 680.12% to 11.5 in 2026.
- The last three Interest Coverage Ratio figures came in at 11.5 (Q1 2026), 1.47 (Q4 2025), and 2.22 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | 49.84 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.50 |
| Dec 31, 2025 | 1.47 |
| Sep 30, 2025 | -2.22 |
| Jun 30, 2025 | 3.52 |
| Mar 31, 2025 | 9.74 |
| Dec 31, 2024 | 8.79 |
| Sep 30, 2024 | 4.51 |
| Jun 30, 2024 | 2.25 |
| Mar 31, 2024 | 17.87 |
| Dec 31, 2023 | 4.88 |
| Sep 30, 2023 | 31.66 |
| Jun 30, 2023 | 20.42 |
| Mar 31, 2023 | 20.02 |
| Dec 31, 2022 | 11.06 |
| Sep 30, 2022 | 11.37 |
| Jun 30, 2022 | 27.82 |
| Mar 31, 2022 | 40.50 |
| Dec 31, 2021 | 107.24 |
| Sep 30, 2021 | 115.92 |
| Jun 30, 2021 | 14.19 |